REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/05/2025
Back to search
Official data from USPTO
MEDIDATA RAVEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEDIDATA RAVEX
ST13
US500000086979160Class
42
Filing
86979160
Registration
4994931
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/06/2025
Trademark type
Word
Nice classes
42
Filing date
05/11/2015
Registration date
07/05/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/06/2021
Last transaction
07/06/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/05/2015
First use in commerce
09/05/2015
Drawing code
4
Owner type
03
Owner location
9th Floor, NY
Examiner
FOSDICK, GEOFFREY
Law office
M20
Current location
TMO LAW OFFICE 111
Holders and representatives
Holders
Medidata Solutions, Inc.
Representatives
Jordan A. LaVine Flaster Greenberg P C
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Software as a service (saas) solutions featuring software for capturingmanaging and reporting data and information in the fields of medical clinical trials and medical researchfor designingmanagingexecuting medical clinical trials and medical research and medical clinical trial and medical research protocolsfor forecasting and benchmarking budgets and costs in medical clinical trials and medical researchfor medical coding in medical clinical trials and medical researchfor the collection of information and data in medical clinical trials and medical researchfor evaluating and measuring the performance and results of medical clinical trials and medical researchfor capturingmanagingorganizing and reporting the results of medical clinical trials and medical researchfor monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical researchfor medical clinical trial and medial research user and learning managementfor medical clinical trial and medical research operational reporting and analyticsfor medical clinical trial and medical research patient randomization and supply management; providing temporary use of online non-downloadable computer software for capturingmanaging and reporting data and information in the fields of medical clinical trials and medical researchfor designingmanagingexecuting medical clinical trials and medical research and medical clinical trial and medical research protocolsfor forecasting and benchmarking budgets and costs in medical clinical trials and medical researchfor medical coding in medical clinical trials and medical researchfor the collection of information and data in medical clinical trials and medical researchfor evaluating and measuring the performance and results of medical clinical trials and medical researchfor managingorganizing and reporting the results of medical clinical trials and medical researchfor monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical researchfor medical clinical trial and medical research user and learning managementfor medical clinical trial and medical research operational reporting and analyticsfor medical clinical trial and medical research patient randomization and supply management
Publications
History of USPTO decisions and trademark events.
26 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/06/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/06/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/06/2021
E815
TEAS SECTION 8 & 15 RECEIVED
08/03/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/05/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/05/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/02/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/01/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/25/2016
DPCC
DIVISIONAL PROCESSING COMPLETE
05/25/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/24/2016
IUAF
USE AMENDMENT FILED
04/13/2016
DRRR
DIVISIONAL REQUEST RECEIVED
04/13/2016
EISU
TEAS STATEMENT OF USE RECEIVED
04/13/2016
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
04/13/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/13/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/18/2015
PUBO
PUBLISHED FOR OPPOSITION
08/18/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/29/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/16/2015
ALIE
ASSIGNED TO LIE
07/16/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2015
DOCK
ASSIGNED TO EXAMINER
06/24/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/19/2015
NWAP
NEW APPLICATION ENTERED
05/14/2015
Continuous trademark protection
Get notified about every new filing that threatens MEDIDATA RAVEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.